Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
Parkinson disease (PD) is a neurodegenerative disease mainly characterized by the loss of nigral dopaminergic neurons in the substantia nigra pars compacta. Patients suffering from PD develop severe motor dysfunctions and a myriad of non-motor symptoms. The treatment mainly consists of increasing ce...
Saved in:
Main Authors: | Victor A. D. Holanda (Author), Julia J. Didonet (Author), Manara B. B. Costa (Author), Adriano H. do Nascimento Rangel (Author), Edilson D. da Silva (Author), Elaine C. Gavioli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics
by: Donald R. Branch
Published: (2011) -
Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons
by: Csaba eAdori, et al.
Published: (2015) -
Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning
by: Ahmet Oguzhan Bicakci, et al.
Published: (2021) -
Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
by: Xiaofang Xu, et al.
Published: (2021) -
Functional and genetic characterization of neuropeptide Y-like receptors in Aedes aegypti.
by: Jeff Liesch, et al.
Published: (2013)